31![Article DOI: [removed]bbeq[removed]INTELLECTUAL PROPERTY RIGHTS Article DOI: [removed]bbeq[removed]INTELLECTUAL PROPERTY RIGHTS](https://www.pdfsearch.io/img/539c784298ee95c73530ffce4ad13401.jpg) | Add to Reading ListSource URL: s2b.mon.bgLanguage: English - Date: 2013-01-19 04:56:41
|
---|
32![BE – Lundbeck v. Tiefenbacher, Ratiopharm, Teva and Eurogenerics (escitalopram) Steven Cattoor HOYNG MONEGIER Less than a year after the first instance judgment of the Brussels Commercial Court (see http://www.eplawpat BE – Lundbeck v. Tiefenbacher, Ratiopharm, Teva and Eurogenerics (escitalopram) Steven Cattoor HOYNG MONEGIER Less than a year after the first instance judgment of the Brussels Commercial Court (see http://www.eplawpat](https://www.pdfsearch.io/img/3f20c1c163e25f31e499d796023d2b34.jpg) | Add to Reading ListSource URL: www.eplawpatentblog.comLanguage: English - Date: 2012-09-24 12:01:00
|
---|
33![Chapter 1 Inclusion Complexation as a Tool in Resolution of Racemates and Separation of Isomers ZOFIA URBANCZYK-LIPKOWSKA Institute of Organic Chemistry, Polish Academy of Sciences, 01-224 Chapter 1 Inclusion Complexation as a Tool in Resolution of Racemates and Separation of Isomers ZOFIA URBANCZYK-LIPKOWSKA Institute of Organic Chemistry, Polish Academy of Sciences, 01-224](https://www.pdfsearch.io/img/30bfedc84db6ff145090a6bace430760.jpg) | Add to Reading ListSource URL: media.wiley.comLanguage: English - Date: 2007-10-05 18:42:06
|
---|
34![7 June 2013 First Division[removed]TT in the name of the King 7 June 2013 First Division[removed]TT in the name of the King](https://www.pdfsearch.io/img/699494457ec10d45cb5b2c1eddd89f6c.jpg) | Add to Reading ListSource URL: www.eplawpatentblog.comLanguage: English - Date: 2013-07-01 04:07:48
|
---|
35![-UNOFFICIAL TRANSLATIONJUDGMENT The Court of Appeal of BRUSSELS, eighth chamber, after deliberation, declares the following: IN THE CASE OF: LUNDBECK A/S, appellant VERSUS -UNOFFICIAL TRANSLATIONJUDGMENT The Court of Appeal of BRUSSELS, eighth chamber, after deliberation, declares the following: IN THE CASE OF: LUNDBECK A/S, appellant VERSUS](https://www.pdfsearch.io/img/d327a3502911610849554cdbec63fb31.jpg) | Add to Reading ListSource URL: www.eplawpatentblog.comLanguage: English - Date: 2012-10-17 09:32:19
|
---|
36![](https://www.pdfsearch.io/img/08c301b9d75f84814030b8a8ddbaeddf.jpg) | Add to Reading ListSource URL: www.eplawpatentblog.comLanguage: English - Date: 2011-04-12 10:37:08
|
---|
37![](https://www.pdfsearch.io/img/38ae0f3cbd9a83abfa76fcae023e1c55.jpg) | Add to Reading ListSource URL: ipophil.gov.phLanguage: English - Date: 2013-05-21 02:24:55
|
---|
38![Title, Table of Contents2010.indd Title, Table of Contents2010.indd](https://www.pdfsearch.io/img/dfdb4a0fb7fdb15c6505b8b4262a4a0a.jpg) | Add to Reading ListSource URL: digital.library.okstate.eduLanguage: English - Date: 2012-11-15 10:40:29
|
---|
39![77 Identification and Enantiomeric Separation of (+)- and (-)-(E[removed],4-Diaminopyrimidin-5ylmethyl)-2,3dimethoxyphenyl]-1(1-propyl-1H-phthalazin-2-yl)propenone by Supercritical Fluid Chromatography Richard A. Bunce 77 Identification and Enantiomeric Separation of (+)- and (-)-(E[removed],4-Diaminopyrimidin-5ylmethyl)-2,3dimethoxyphenyl]-1(1-propyl-1H-phthalazin-2-yl)propenone by Supercritical Fluid Chromatography Richard A. Bunce](https://www.pdfsearch.io/img/1ecffe51701644c72467251850acaaad.jpg) | Add to Reading ListSource URL: digital.library.okstate.eduLanguage: English - Date: 2012-11-14 12:42:27
|
---|
40![Therapeutic Products Programme Holland Cross, Tower “B” 1600, Scott Street Address Locator # 3102D1 OTTAWA (Ontario) K1A 1B6 Therapeutic Products Programme Holland Cross, Tower “B” 1600, Scott Street Address Locator # 3102D1 OTTAWA (Ontario) K1A 1B6](https://www.pdfsearch.io/img/4c4060cf1260cfafa13b2ce7a8077310.jpg) | Add to Reading ListSource URL: www.hc-sc.gc.caLanguage: English - Date: 2013-07-12 14:26:51
|
---|